Lv1
40 积分 2026-05-12 加入
Two‐tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross‐sectional study
1个月前
已完结
Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease
1个月前
已完结
Assessing the risk of metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: is the Fibrosis-4 index still a reliable tool?
1个月前
已完结
Cardiovascular–kidney–metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
1个月前
已完结
Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings
1个月前
已完结
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography ( GOLDMINE ): A Multi‐Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes
2个月前
已完结
Efficacy of Vitamin E on Lipid Profile in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta‐Analysis
2个月前
已完结
Differential Effects of Cardiometabolic Risk Factors on All-Cause Mortality in United States Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2个月前
已完结
皖公网安备34019202002308
